Effects of whole cell sonicates of Treponema lecithinolyticum on osteoclast differentiation

Journal of Periodontology

Volumn 72, Issue 9, 2001, Pages 1172-1177

  Choi, Bong Kyu ^a   Ohk, Seung Ho ^a   Lee, Hyun Jung ^a   Kang, Jung Hwa ^a   Jeong, Gook Jin ^a   Yoo, Yun Jung ^a  

^a Yonsei University College of Dentistry   (South Korea)

Author keywords

Alveolar bone loss microbiology; Osteoclasts growth; Periodontal diseases microbiology; Treponema lecithinolyticum

Indexed keywords

CARRIER PROTEIN; INDOMETACIN; MEMBRANE PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; OSTEOCLAST DIFFERENTIATION FACTOR; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TNFRSF11A PROTEIN, MOUSE; TNFSF11 PROTEIN, MOUSE;

ANIMAL; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; COCULTURE; CULTURE MEDIUM; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; MICROBIOLOGY; MOUSE; NONPARAMETRIC TEST; OSTEOCLAST; OSTEOLYSIS; PATHOGENICITY; TREPONEMA; ULTRASOUND;

ALVEOLAR BONE LOSS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BONE MARROW CELLS; CARRIER PROTEINS; CELL DIFFERENTIATION; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; INDOMETHACIN; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED ICR; OSTEOCLASTS; PROSTAGLANDIN ANTAGONISTS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; SONICATION; STATISTICS, NONPARAMETRIC; TREPONEMA;

EID: 0035459585     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2000.72.9.1172     Document Type: Article

References (33)

1. Schwartz Z, Goultschin J, Dean DD, Boyan BD. Mechanisms of alveolar bone destruction in periodontitis. Periodontol 2000 1997;14:158-172.
2. Loesche WJ. The role of spirochetes in periodontal disease. Adv Dent Res 1988;2:275-283.
3. Listgarten MA, Levin S, Positive correlation between the proportions of subgingival spirochetes and motile bacteria and susceptibility of human subjects to periodontal deterioration. J Clin Periodontol 1981;8:122-138.
4. Salvador SL, Syed SA, Loesche WJ. Comparison of three dispersion procedures for quantitative recovery of cultivable species of subgingival spirochetes. J Clin Microbiol 1987;25:2230-2232.
5. Wyss C. Growth of Porphyromonas gingivalis, Treponema denticola, T. pectinovorum, T. socranskii, and T. vincentii in a chemically defined medium. J Clin Microbiol 1992;30:2225-2229.
6. Wyss C, Choi BK, Schüpbach P, Guggenheim B, Göbel UB. Treponema maltophilum sp. nov., a small oral spirochete isolated from human periodontal lesions. Int J Syst Bacteriol 1996;46:745-752.
7. Umemoto T, Nakazawa F, Hoshino E, Okada K, Fukunaga M, Namikawa I. Treponema medium sp. nov., isolated from human subgingival dental plaque. Int J Syst Bacteriol 1997;47:67-72.
8. Wyss C, Choi BK, Schüpbach P, Guggenheim B, Göbel UB. Treponema amylovorum sp. nov., a saccharolytic spirochete of medium size isolated from an advanced human periodontal lesion. Int J Syst Bacteriol 1997; 47:842-845.
9. Wyss C, Choi BK, Schüpbach P, Moter A, Guggenheim B, Göbel UB. Treponema lecithinolyticum sp. nov., a small saccharolytic spirochaete with phospholipase A and C activities associated with periodontal diseases. Int J Syst Bacteriol 1999;49:1329-1339.
10. Beausejour A, Deslauriers N, Grenier D. Activation of the interleukin-1β precursor by Treponema denticola: a potential role in chronic inflammatory periodontal diseases. Infect Immun 1997;65:3199-3202.
11. Ishihara K, Okuda K. Molecular pathogenesis of the cell surface proteins and lipids from Treponema denticola. FEMS Microbiol Lett 1999;181:199-204.
12. Chan ECS, McLaughlin R. Taxonomy and virulence of oral spirochetes. Oral Microbiol Immunol 2000;15:1-9.
13. Moter A, Hoenig C, Choi BK, Riep B, Göbel UB. Molecular epidemiology of oral treponemes associated with periodontal disease. J Clin Microbiol 1998;36:1399-1403.
14. Choi BK, Paster BJ, Dewhirst FE, Göbel UB. Diversity of cultivable and uncultivable oral spirochetes from a patient with severe destructive periodontitis. Infect Immun 1994;62:1889-1895.
15. Akatsu T, Takahashi N, Udagawa N, et al. Parathyroid hormone (PTH)-related protein is a potent stimulator of osteoclast-like multinucleated cell formation to the same extent as PTH in mouse marrow cultures. Endocrinol 1989;125:20-27.
16. Takahashi N, Akatsu T, Udagawa N, et al. Osteoblastic cells are involved in osteoclast formation. Endocrinol 1988;123:2600-2602.
17. 3 in osteoclast differentiation and function. Methods Enzymol 1997;282:223-235.
18. Akatsu T, Takahashi N, Udagawa N, et al. Role of prostaglandins in inerleukin-1-induced bone resorption in mice in vitro. J Bone Miner Res 1991;6:183-189.
19. Tamura T, Udagawa N, Takahashi N, et al. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci (USA) 1993;90:11924-11928.
20. 2 stimulates osteoclast-like cell formation and bone-resorbing activity via osteoblasts: role of cAMP-dependent protein kinase. J Bone Miner Res 1996;11:62-71.
21. Martin TJ, Romas E, Gillespie MT. Interleukins in the control of osteoclast differentiation. Crit Rev Eukaryot Gene Expr 1998;8:107-123.
22. 2, or parathyroid hormone in the microenviroment of bone. Biochem Biophy Res Commun 1998;246:337-341.
23. Yasuda H, Shima N, Nakagawa N, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci (USA) 1998;95: 3597-3602.
24. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 1999;20: 345-357.
25. Wilson M, Meghji S, Barber P, Henderson B. Biological activities of surface-associated material from Porphyromonas gingivalis. FEMS Immunol Med Microbiol 1993;6:147-155.
26. Kawata Y, Hanazawa S, Amano S, et al. Porphyromonas gingivalis fimbriae stimulate bone resorption in vitro. Infect Immun 1994;62:3012-3016.
27. Meghji S, Wilson M, Barber P, Henderson, B. Bone resorbing activity of surface-associated material from Actinobacillus actinomycetemcomitans and Eikenella corrodens. J Med Microbiol 1994;41:197-203.
28. Kirby AC, Meghji S, Nair SP, et al. The potent bone-resorbing mediator of Actinobacillus actinomycetemcomitans is homologous to the molecular chaperone GroEL. J Clin Invest 1995;96:1185-1194.
29. Nishihara T, Ueda N, Amano K, et al. Actinobacillus actinomycetemcomitans Y4 capsular-polysaccharide-like polysaccharide promotes osteoclast-like cell formation by interleukin-1α production in mouse bone marow cultures. Infect Immun 1995;63:1893-1898.
30. Miyata Y, Takeda H, Kitano S, Hanazawa S. Porphyromonas gingivalis lipopolysaccharide-stimulated bone resorption via CD14 is inhibited by broad-spectrum antibiotics. Infect Immun 1997;65:3513-3519.
31. Ueda N, Koide M, Ohguchi M, et al. Involvement of prostaglandin E2 and interleukin-1α in the differentiation and survival of osteoclasts induced by lipopolysaccharide from Actinobacillus actinomycetemcomitans Y4. J Periodont Res 1998;33:509-516.
32. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
33. Gopalsami C, Yotis W, Corrigan K, Schade S, Keene J, Simonson L. Effect of outer membrane of Treponema denticola on bone resorption. Oral Microbiol Immunol 1993;8:121-124.